v3.24.1.1.u2
Warrant Liability
3 Months Ended
Mar. 31, 2024
Warrants and Rights Note Disclosure [Abstract]  
Warrant Liability

Note 11. WARRANT LIABILITY

When the Company issues warrants, it evaluates the proper balance sheet classification of the warrant to determine whether it should be classified as equity or as a derivative liability on the consolidated balance sheets. In accordance with ASC 815-40, “Derivatives and Hedging-Contracts in the Entity’s Own Equity” (“ASC 815-40”), the Company classifies a warrant as equity so long as it is “indexed to the Company’s equity” and several specific conditions for equity classification are met. A warrant is not considered indexed to the Company’s equity, in general, when it contains certain types of exercise contingencies or adjustments to the exercise price. If a warrant is not indexed to the Company’s own common stock or it has net cash settlement that results in the warrants to be accounted for under ASC 480, “Distinguishing Liabilities from Equity”, or ASC 815-40, it is classified as a derivative liability which is carried on the consolidated balance sheet at fair value with any changes in its fair value recognized currently in the statement of operations.

As of March 31, 2024, the Company had recognized a warrant liability for the following securities which are convertible into, or allow the purchase of, our Class A Common Stock, including: (i) 2,950,157 Public Warrants outstanding, each exercisable to purchase 1/25th of one share of our Class A Common Stock (but only exercisable in lots of 25 to purchase whole shares); (ii) 894,754,824 New Warrants outstanding, each exercisable to purchase 1/25th of one share of our Class A Common Stock (but only exercisable in lots of 25 to purchase whole shares); and (iii) the VRM Warrants, entitling VRM to purchase 48,517,817 shares of Class A Common Stock at a purchase price of $0.0001 per share for a period of two years from issuance, exercisable on a cashless basis.

The warrant liability includes the mark-to-market fair value of the warrants discussed above. The fair value of the warrant liability is derived considering the potential shares issuable for each warrant and using the price of the Company’s Class A Common Stock as of the most recent balance sheet date, which is a quoted price in active markets.

The table below presents a roll-forward of the warrant liability from December 31, 2023 to March 31, 2024:

 

in thousands

 

 

 

Warrant Liability

 

Balance at December 31, 2023

$

(268

)

Issuance of new warrants

 

(84,508

)

Change in fair value of outstanding warrants

 

51,460

 

Balance at March 31, 2024

$

(33,316

)

A summary of activity of the shares resulting from the exercise of warrants during the three months ended March 31, 2024 is as follows:

 

 

 

 

 

Weighted Average

 

 

 

# of Shares

 

 

Exercise Price

 

Balance at December 31, 2023

 

 

35,908,200

 

 

$

286.56

 

Issued

 

 

48,517,817

 

 

$

0.0001

 

Exercised

 

 

 

 

$

 

Expired

 

 

 

 

$

 

Balance at March 31, 2024

 

 

84,426,017

 

 

$

121.88

 

Refer to Note 3, Business Combination, for discussion of the terms of the Public Warrants and New Warrants, and to Note 4, Asset Acquisitions, for discussion of the terms of the VRM Warrants.